Molecure SA
F:1B1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Molecure SA
F:1B1
|
PL |
|
T
|
Thor Explorations Ltd
OTC:THXPF
|
CA |
|
A
|
Ahlers AG
F:AAH
|
DE |
|
Tsentral'nyi Telegraf PAO
MOEX:CNTL
|
RU |
|
RTCore Inc
OTC:RTME
|
US |
|
M
|
Mehta Integrated Finance Ltd
BSE:511377
|
IN |
|
I
|
InRob Tech Ltd
OTC:IRBL
|
US |
|
Energa SA
F:EN2
|
PL |
|
C
|
Century Global Commodities Corp
OTC:CEUMF
|
HK |
|
M
|
My Rewards International Ltd
ASX:MRI
|
AU |
|
Edap Tms SA
NASDAQ:EDAP
|
FR |
|
CVD Equipment Corp
NASDAQ:CVV
|
US |
|
Komax Holding AG
SIX:KOMN
|
CH |
|
W
|
Wangton Capital Corp
XTSX:WT.H
|
CA |
|
G
|
GACM Technologies Ltd
BSE:570005
|
IN |
|
M
|
Mayo Human Capital Inc
TPEX:6738
|
TW |
|
M
|
Mondee Holdings Inc
OTC:MOND
|
US |
|
M
|
Metals Creek Resources Corp
OTC:MCREF
|
CA |
|
Rubis SCA
F:BYN
|
FR |
|
L
|
Liberty One Lithium Corp
F:L1TA
|
CA |
Bankruptcy Probability
Molecure SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Molecure SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PL |
M
|
Molecure SA
WSE:MOC
|
152.3m PLN |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.2T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
658.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
375.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
241.6B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
187.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
281.5B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Molecure SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Molecure SA has total debt of 3.1m PLN. This includes both short-term (0 PLN) and long-term (3.1m PLN) debt.
You can find a full breakdown on its Balance Sheet.
